Fukuoka, Japan

Chisato Emura


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chisato Emura: Innovator in Nucleic Acid Technology

Introduction

Chisato Emura is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of nucleic acid technology, particularly in the regulation of gene expression. With a total of 2 patents, his work is paving the way for advancements in genetic research and therapeutic applications.

Latest Patents

Emura's latest patents focus on a single-stranded nucleic acid molecule designed to regulate the expression of genes with delivery functions. This innovative nucleic acid is structured to inhibit the expression of target genes effectively. The design includes a 5'-side region (Xc), a linker region (Lx), an inner region (Z), another linker region (Ly), and a 3'-side region (Yc). The inner region (Z) is formed by linking the inner 5'-side region (X) and the inner 3'-side region (Y). The complementary nature of the 5'-side region (Xc) and the 3'-side region (Yc) to their respective inner regions enhances the nucleic acid's functionality. Additionally, at least one of the regions contains an expression inhibitory sequence, which is crucial for inhibiting target gene expression.

Career Highlights

Chisato Emura is currently associated with Bonac Corporation, where he continues to innovate in the field of genetic engineering. His work has garnered attention for its potential applications in various biotechnological fields.

Collaborations

Emura collaborates with talented individuals such as Tadaaki Ohgi and Eriko Aoki, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work.

Conclusion

Chisato Emura's contributions to nucleic acid technology exemplify the innovative spirit of modern science. His patents reflect a commitment to advancing genetic research and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…